Rob Stein Rob Stein is a Correspondent and Senior Editor on NPR's Science Desk.
Maggie Starbard/NPR
Rob Stein
Maggie Starbard/NPR

Rob Stein

Correspondent and Senior Editor, Science Desk

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

[+] read more[-] less

Story Archive

Michele Comisky of Vienna, Va., enrolled her 8-year-old son, Jackson, in a study to test the value of probiotics in preventing the gut distress often experienced when taking antibiotics. Rob Stein/NPR hide caption

toggle caption
Rob Stein/NPR

Could Probiotics Protect Kids From A Downside Of Antibiotics?

  • Download
  • <iframe src="https://www.npr.org/player/embed/567746569/569815415" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Australia had a particularly hard flu season this year, which may predict similar challenges for the U.S. Pascal Pochard-Casabianca/AFP/Getty Images hide caption

toggle caption
Pascal Pochard-Casabianca/AFP/Getty Images

In The U.S., Flu Season Could Be Unusually Harsh This Year

  • Download
  • <iframe src="https://www.npr.org/player/embed/569379155/569983815" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Pasieka/Science Photo Library/Getty Images

Gene Therapy Shows Promise For A Growing List Of Diseases

  • Download
  • <iframe src="https://www.npr.org/player/embed/565728869/567155749" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Kolbi Brown (left), a program manager at Harlem Hospital in New York, helps Karen Phillips sign up to receive more information about the All of Us medical research program, during a block party outside the Abyssinian Baptist Church in Harlem. Elias Williams for NPR hide caption

toggle caption
Elias Williams for NPR

Troubling History In Medical Research Still Fresh For Black Americans

  • Download
  • <iframe src="https://www.npr.org/player/embed/556673640/560089163" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Scientists have used a new gene-editing technique to create pigs that can keep their bodies warmer, burning more fat to produce leaner meat. Infrared pictures of 6-month-old pigs taken at zero, two, and four hours after cold exposure show that the pigs' thermoregulation was improved after insertion of the new gene. The modified pigs are on the right side of the images. Zheng et al. / PNAS hide caption

toggle caption
Zheng et al. / PNAS

CRISPR Bacon: Chinese Scientists Create Genetically Modified Low-Fat Pigs

  • Download
  • <iframe src="https://www.npr.org/player/embed/559060166/559889678" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. Spark Therapeutics hide caption

toggle caption
Spark Therapeutics

FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness

  • Download
  • <iframe src="https://www.npr.org/player/embed/557183740/557444730" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

3 Americans Win Nobel In Medicine For Circadian Rhythm Research

  • Download
  • <iframe src="https://www.npr.org/player/embed/555170222/555170223" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Vegas Shooting Dominates News; 3 Americans Win Nobel In Medicine

  • Download
  • <iframe src="https://www.npr.org/player/embed/555018505/555035675" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Nobel Prize In Medicine Is Awarded To 3 Americans

  • Download
  • <iframe src="https://www.npr.org/player/embed/554994453/554994454" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Piper Su, seen here with her son, Elliot, lives in Alexandria, Va. She has registered with several transplant centers in hopes of increasing the odds of getting an organ. Courtesy of Piper Su hide caption

toggle caption
Courtesy of Piper Su

Searching For A Fairer Way To Distribute Donor Livers

  • Download
  • <iframe src="https://www.npr.org/player/embed/549224583/553662037" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Kathy Niakan, a developmental biologist at the Francis Crick Institute in London, used the CRISPR gene editing technique to find out how a gene affects the growth of human embryos. Courtesy of The Francis Crick Institute hide caption

toggle caption
Courtesy of The Francis Crick Institute

Editing Embryo DNA Yields Clues About Early Human Development

  • Download
  • <iframe src="https://www.npr.org/player/embed/551779921/552418326" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Scientists have created a treatment in which genetically modified T cells, shown in blue, can attack cancer cells, shown in red. Steve Gschmeissner/Science Source hide caption

toggle caption
Steve Gschmeissner/Science Source

FDA Approves First Gene Therapy For Leukemia

  • Download
  • <iframe src="https://www.npr.org/player/embed/547293551/547373424" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript